NovaBay Pharmaceuticals, Inc. (NBY)

ASE – Real Time Price. Currency in USD

1.95

+0.36 (22.64%)

At close: Apr 2, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

10M

14M

Cost of goods sold

-140K

-341K

-4M

-7M

Gross Profit

-140K

-341K

Operating expenses (excl. COGS)

-7M

-10M

-15M

Operating Income

-8M

-7M

-4M

-8M

Non-operating income, total

-634M

-1M

-2M

-3M

Pretax income

-642M

-9M

-6M

-11M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

-6M

Net income before discontinued operations

-642M

-9M

-6M

-16M

NovaBay Pharmaceuticals, Inc. (NBY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

NovaBay Pharmaceuticals, Inc. (NBY)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

NovaBay Pharmaceuticals, Inc. (NBY)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

NovaBay Pharmaceuticals, Inc. (NBY)

Income Statement (Annual)

Income Statement (Annual)